The interleukin 2 receptor in the hypereosinophilic syndrome.

Abstract excerpt

The hypereosinophilic syndrome (HES) has been previously described as a clinicobiological entity characterized by a blood eosinophil count of over 1.5 x 10(9)/L of unknown cause associated with several clinical complications. In reality, HES is a heterogeneous group of diseases with variable and unpredictable progress in visceral lesions, thought to be related to the deleterious effects of tissue eosinophil...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Biomarkers
• Share to Eosinophils
• Share to Interleukin-2